S17G (p.Ser17Gly) variant of CEBPA (P49715)
S17G (p.Ser17Gly) in CEBPA (P49715) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Acute myeloid leukemia. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes published literature and structural context.
S17G (p.Ser17Gly) variant details
- p.Ser17Gly
- rs2145264889
- ClinGen CA405275785
- ClinVar RCV001970813
- Ensembl rs2145264889
- Uncertain significance
- Acute myeloid leukemia
- Missense
- Variant Prioritization Score for Impact Estimate 0.311
- AlphaMissense 0.16
- MetaLR 0.08
- MetaSVM -1.04
- PolyPhen-2 0.01
- SIFT 0.03
- EVE 0.28
- ClinVar: Uncertain significance (Acute myeloid leukemia)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Structural context available
- Cited in: CEBPA-Associated Familial Acute Myeloid Leukemia (AML). (PMID 20963938)
- Cited in: NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. (PMID 22138009)